Managing myelodysplastic syndromes in very old patients: a teaching case report
Pasquale Niscola, Massimiliano Palombi, Malgorzata Monika Trawinska, Andrea Tendas, Marco Giovannini, Laura Scaramucci, Alessio Perrotti, Paolo de Fabritiis Hematology Unit, Sant'Eugenio Hospital, Rome, Italy Abstract: The introduction of hypomethylating agents in the treatment of myelodysp...
Guardado en:
Autores principales: | Niscola P, Palombi M, Trawinska MM, Tendas A, Giovannini M, Scaramucci L, Perrotti A, de Fabritiis P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b5a965fe9244854bc76692f07bfa05e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case
por: Palacios-Campos,Adriana, et al.
Publicado: (2020) -
Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
por: Ritchie EK
Publicado: (2012) -
Lymphocytic Infiltrate and p53 Protein Expression as Predictive Markers of Response and Outcome in Myelodysplastic Syndromes Treated with Azacitidine
por: Carlo Pescia, et al.
Publicado: (2021) -
Managing myelodysplastic symptoms in elderly patients
por: R Ria, et al.
Publicado: (2009) -
Free Flap Reconstruction of the Extremities in Patients Who are ≥65 Years Old: A Single-Center Retrospective 1-to-1 Matched Analysis
por: Spindler N, et al.
Publicado: (2021)